527 studies found for:    amyloid
Show Display Options
Rank Status Study
1 Recruiting Escitalopram Effects on CSF Amyloid Beta
Condition: Amyloid Beta Protein
Intervention: Drug: Escitalopram or Placebo
2 Unknown  F-18-AV-45 Uptake, Spot Sign Presence and Cerebral Amyloid Angiopathy (CAA) in Primary Intracranial Hemorrhage (ICH)
Condition: Cerebral Amyloid Angiopathy
Intervention:
3 Completed
Has Results
Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients
Condition: Parkinson's Disease
Intervention: Drug: florbetapir F 18
4 Completed
Has Results
Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.
Conditions: Down Syndrome;   Amyloid Beta-protein
Intervention: Drug: Florbetaben (BAY94-9172)
5 Completed
Has Results
PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus
Condition: Normal Pressure Hydrocephalus
Intervention: Drug: [18F] Flutemetamol
6 Recruiting Amyloïd Load in Elderly Population: Effect of Cognitive Reserve
Conditions: Plaque, Amyloid;   Cognitive Deficits
Interventions: Other: PET;   Other: MRI;   Other: neuropsychological tests
7 Completed
Has Results
Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects
Condition: Healthy
Intervention: Drug: [18F] Flutemetamol
8 Enrolling by invitation CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention:
9 Completed
Has Results
Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain
Condition: Alzheimer's Disease
Intervention: Drug: florbetapir F 18
10 Recruiting Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy
Conditions: Intracerebral Hemorrhage;   Cerebral Amyloid Angiopathy;   Ischemic Stroke
Intervention:
11 Recruiting Efficacy and Safety of ISIS-TTR Rx in Familial Amyloid Polyneuropathy
Condition: Familial Amyloid Polyneuropathy
Interventions: Drug: ISIS-TTR Rx;   Drug: Placebo
12 Enrolling by invitation Open-Label Extension Assessing Long Term Safety and Efficacy of ISIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP)
Condition: Familial Amyloid Polyneuropathy
Intervention: Drug: ISIS-TTR Rx
13 Recruiting Amyloid Imaging and Cognitive Impairment After Intracerebral Hemorrhage
Condition: Non Traumatic Primary Intracerebral Hemorrhage
Intervention: Other: Pet AV-45 (Florbetapir F 18) Cerebral Amyloid imaging
14 Completed Radioimmunoimaging of Light Chain (AL) Amyloidosis
Condition: AL Amyloidosis
Intervention: Biological: Single infusion of 124I-labeled anti-amyloid mAb 11-1F4: 2 mCi (1 mg)
15 Completed Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease
Conditions: Alzheimer's Disease;   Posterior Cortical Atrophy;   Logopenic Progressive Aphasia
Intervention:
16 Active, not recruiting Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology
Condition: Alzheimer Disease
Intervention: Drug: Florbetaben (BAY94-9172)
17 Recruiting Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy
Condition: Cerebral Amyloid Angiopathy
Interventions: Biological: Ponezumab;   Other: placebo
18 Enrolling by invitation Imaging of Brain Amyloid Plaques in the Aging Population
Conditions: Alzheimer's Disease;   Dementia With Lewy Bodies;   Frontotemporal Dementia;   Vascular Dementia
Interventions: Drug: Pittsburgh Compound B (C-11 PiB);   Drug: F-18 FDG
19 Completed Efficacy and Safety of Plasma Exchange With 5% Albutein in Beta-Amyloid Peptide Clearance in Cerebrospinal Fluid
Condition: Alzheimer's Disease
Intervention: Biological: Albutein 5%
20 Enrolling by invitation Amyloid Accumulation After Mild Traumatic Brain Injury
Condition: Traumatic Brain Injury
Intervention: Drug: [18F]AV-45 PET amyloid binding imaging

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years